H. Lode - Publications, H-index & Citations

H. Lode

Bayer AG

58H指数

516论文数

1.1W被引数

收录论文 40

发表时间

Community-acquired pneumonia - An EFIM guideline critical appraisal adaptation for internists

EUROPEAN JOURNAL OF INTERNAL MEDICINE

IF6.1

2022-12-01

PREAI

Er, Ahmet Gorkem; Alonso, Alberto Antonio Romero; Marin-Leon, Ignacio; Sayiner, Abdullah; Bassetti, Stefano; Demirkan, Kutay; Lacor, Patrick; Lode, Hartmut; Lesniak, Wiktoria; Tanriover, Mine Durusu; Kalyoncu, Ali Fuat; Merchante, Nicolas; Unal, Serhat

Impact of Bacterial Toxins in the Lungs

TOXINS

IF4

2020-04-02

OAAI

Lucas, Rudolf; Hadizamani, Yalda; Gonzales, Joyce; Gorshkov, Boris; Bodmer, Thomas; Berthiaume, Yves; Moehrlen, Ueli; Lode, Hartmut; Huwer, Hanno; Hudel, Martina; Abu Mraheil, Mobarak; Toque, Haroldo Alfredo Flores; Chakraborty, Trinad; Hamacher, Juerg

A European care bundle for prevention of ventilator-associated pneumonia

INTENSIVE CARE MEDICINE

IF21.2

2010-03-18

179

OAAI

Rello, Jordi; Lode, Hartmut; Cornaglia, Giuseppe; Masterton, Robert

Influence of azithromycin and clarithromycin on macrolide susceptibility of viridans streptococci from the oral cavity of healthy volunteers

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

IF3

2008-05-30

PREAI

Eisenblaetter, M.; Klaus, C.; Pletz, M. W. R.; Orawa, H.; Hahn, H.; Wagner, J.; Lode, H.

Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: The MOTIV study - A randomized clinical trial

CLINICAL INFECTIOUS DISEASES

IF7.3

2008-05-15

PREAI

Torres, Antoni; Garau, Javier; Arvis, Pierre; Carlet, Jean; Choudhri, Shurjeel; Kureishi, Amar; Le Berre, Marie-Aude; Lode, Hartmut; Winter, John; Read, Robert C.

Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults:: Conjugate vaccine elicits improved antibacterial immune responses and immunological memory

CLINICAL INFECTIOUS DISEASES

IF7.3

2008-04-01

226

OAAI

de Roux, Andres; Schmoeele-Thoma, B.; Siber, G. R.; Hackell, J. G.; Kuhnke, A.; Ahlers, N.; Baker, S. A.; Razmpour, A.; Emini, E. A.; Fernsten, P. D.; Gruber, W. C.; Lockhart, S.; Burkhardt, O.; Welte, T.; Lode, H. M.

Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess

INFECTION

IF3.6

2008-01-29

OAAI

Ott, S. R.; Allewelt, M.; Lorenz, J.; Reimnitz, P.; Lode, H.

A prediction model for bacterial etiology in acute exacerbations of COPD

INFECTION

IF3.6

2007-06-01

PREAI

Lode, H.; Allewelt, M.; Balk, S.; De Roux, A.; Mauch, H.; Niederman, M.; Schmidt-Ioanas, M.

Hospital-acquired pneumonia guidelines in Europe: a review of their status and future development

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2007-05-31

OAAI

Mastertonl, R.; Craven, D.; Rei, J.; Struelens, M.; Frirnodt-Moller, N.; Chastre, J.; Ortqvist, A.; Cornagfia, G.; Lode'O, H.; Giarnarellou, H.; Bonten, M. J. M.; Eraksoy, H.; Davey, P.

Piperacillin/tazobactam vs imipenem/cilastatin in the treatment of nosocomial pneumonia - a double blind prospective multicentre study

INFECTION

IF3.6

2006-06-01

OAAI

Schmitt, D. V.; Leitner, E.; Welte, T.; Lode, H.

Apoptosis of peripheral blood neutrophils in COPD exacerbation does not correlate with serum cytokines

RESPIRATORY MEDICINE

IF3.1

2006-04-01

OAAI

Schmidt-Ioanas, M; Pletz, MWR; de Roux, A; Lode, H

Mixed community-acquired pneumonia in hospitalised patients 住院患者的混合社区获得性肺炎

EUROPEAN RESPIRATORY JOURNAL

IF21

2006-04-01

OAAI

de Roux, A; Ewig, S; García, E; Marcos, MA; Mensa, J; Lode, H; Torres, A

HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: Results from the CAPO International Cohort Study

CLINICAL INFECTIOUS DISEASES

IF7.3

2005-08-15

OAAI

Christensen, D; Feldman, C; Rossi, P; Marrie, T; Blasi, F; Luna, C; Fernandez, P; Porras, J; Martinez, J; Weiss, K; Levy, G; Lode, H; Gross, P; File, T

Immunogenity of the pneumococcal polysaccharide vaccine in COPD patients. The effect of systemic steroids

RESPIRATORY MEDICINE

IF3.1

2004-12-01

PREAI

de Roux, A; Schmidt, N; Rose, M; Zielen, S; Pletz, M; Lode, H

Antiviral treatment and prophylaxis of influenza in primary care:: German recommendations

JOURNAL OF CLINICAL VIROLOGY

IF3.4

2004-10-01

PREAI

Wutzler, P; Kossow, KD; Lode, H; Ruf, BR; Scholz, H; Vogel, GE; Ehlers, M; Färber, I; Fock, R; Gillissen, A; Heckler, R; Höffken, G; Kossow, KD; Lode, H; Lüdke, HW; Ruf, BR; Schade, S; Scholz, H; Schmidt, RE; Ruf, BR; Schade, S; Scholz, H; Schmidt, RE; Skopnik, H; Vogel, GE; Wutzler, P

Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2004-10-01

103

OAAI

Pletz, MWR; Rau, M; Bulitta, J; De Roux, A; Burkhardt, O; Kruse, G; Kurowski, M; Nord, CE; Lode, H

Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced Amoxicillin-Clavulanate (2,000/125 milligrams) versus those of Amoxicillin-Clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatment of bacterial community-acquired pneumonia in adults

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2004-09-01

OAAI